Signal Genetics Provides Overview of Recent Corporate

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Signal Genetics Provides Overview of Recent Corporate Achievements

CARLSBAD, Calif., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Signal Genetics, Inc. (Nasdaq: SGNL ) (Signal), a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer, today provided a business update and overview of its recent achievements.

Recent Highlights

  • Increased net revenue to $1.3 million for the third quarter, an increase of 32% from the third quarter of 2013
  • Named two key appointments to management team
    • Tamara Seymour, Chief Financial Officer
    • Michael C. Cerio, Senior Vice President, Commercial Strategy and Business Development
  • Expanded sales force with two additional hires
  • Extended exclusive laboratory services agreements with University of Arkansas for Medical Sciences (UAMS)

Samuel D. Riccitelli, Signal's President and Chief Executive Officer, commented, "During the third quarter, we continued to execute on our business strategy by significantly growing our revenue, extending a key relationship and expanding our leadership team. Of note, we grew revenue by 32% during the quarter when compared to the third quarter of 2013, which includes an increase of 128% from non-UAMS hospitals. UAMS is our key partner and we recently extended our exclusive laboratory services agreement with this top research center for the treatment of multiple myeloma. We are excited about the confidence they continue to demonstrate in the Company, but we also realize the importance of growing our revenue through other relationships. We believe the revenue growth we achieved speaks to the growing recognition from physicians of our MyPRS ® test and the benefits it provides in the management of patient care."

Mr. Riccitelli concluded, "In addition, we made two key hires since our initial public offering at the end of June with the appointment of Tamara Seymour as Chief Financial Officer and Michael C. Cerio as Senior Vice President of Commercial Strategy and Business Development. They each bring to the Signal team a wealth of industry knowledge and we look forward to the continued contributions they will make to the Company's long-term success. Along with Tamara and Michael, we have expanded our sales force to three people, all of whom have a tremendous amount of experience in oncology product sales and will be key members of our team as we seek to expand our footprint."

About Signal Genetics, Inc.

Signal Genetics, Inc., headquartered in Carlsbad, California, is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The Company's mission is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions. Signal was founded in January 2010 and became the exclusive licensee in its licensed field to the renowned research on multiple myeloma performed at UAMS, in April 2010.

(Financial Statements to follow.)

Signal Genetics, Inc. and Subsidiaries
Consolidated Balance Sheets
 
  September 30, 2014 December 31, 2013
  (Unaudited)  
ASSETS    
Current assets:    
Cash  $ 6,388,358  $ 209,348
Restricted cash  50,236  50,180
Accounts receivable, net  1,549,998  994,010
Inventory  232,064  356,641
Prepaid expenses and other current assets  434,902  444,369
Total current assets  8,655,558  2,054,548
     
Property and equipment, net  825,882  928,026
Deferred issuance costs  --   655,018
Security deposits  43,326  35,034
     
   $ 9,524,766  $ 3,672,626
     
LIABILITIES AND STOCKHOLDERS' EQUITY/MEMBERS' DEFICIENCY  
Current liabilities:    
Accounts payable and accrued expenses  $ 939,481  $ 689,716
Amounts due to related party  1,045,000  -- 
Note payable - current portion  10,597  42,046
Note payable - related party   --   26,568,554
Total current liabilities  1,995,078  27,300,316
     
Lease termination/abandonment payable  --   259,345
Commitments and contingencies    
     
Stockholders' equity/members' deficiency:    
Common stock, $0.01 par value, 50,000,000 shares authorized, 3,782,629 shares issued and outstanding at September 30, 2014 and no shares issued and outstanding at December 31, 2013  37,826  -- 
Additional paid in capital  39,010,827  -- 
Accumulated deficit  (31,518,965)  -- 
Members' deficiency  --   (23,887,035)
Total members' deficiency/stockholders' equity  7,529,688  (23,887,035)
     
   $ 9,524,766  $ 3,672,626
     
Signal Genetics, Inc. and Subsidiaries
Unaudited Consolidated Statements of Operations
 
  Three Months Ended
  September 30,
2014
September 30,
2013
     
Net revenue  $ 1,300,990  $ 983,589
     
Operating expenses:    
Cost of revenue  871,522  713,200
Selling and marketing  178,816  99,941
General and administrative  1,103,762  435,503
Stock compensation  703,725  -- 
Research and development  76,214  46,604
Total operating expenses  2,934,039  1,295,248
     
Operating loss  (1,633,049)  (311,659)
     
Interest expense  (4,154)  (567,976)
     
Net loss  (1,637,203)  (879,635)
     
Dividend to member unit holder of Myeloma Health LLC  --   (60,000)
     
Net loss attributable to stockholders of Signal Genetics, Inc.  $ (1,637,203)  $ (939,635)
     
Basic and diluted net loss per share:    
Net loss attributable to stockholders of Signal Genetics, Inc.  $ (0.43)  $ (0.35)
     
Weighted average shares outstanding - basic and diluted  3,782,629  2,672,349
     
Signal Genetics, Inc. and Subsidiaries
Unaudited Consolidated Statements of Operations
 
  Nine Months Ended
  September 30,
2014
September 30,
2013
     
Net revenue  $ 3,665,484  $ 3,225,881
     
Operating expenses:    
Cost of revenue  2,333,216  2,110,323
Selling and marketing  325,639  253,094
General and administrative  1,891,006  1,131,555
Stock compensation  3,578,465  -- 
Research and development  148,288  182,193
Total operating expenses  8,276,614  3,677,165
     
Operating loss  (4,611,130)  (451,284)
     
Interest expense  (1,020,801)  (1,505,198)
     
Net loss  (5,631,931)  (1,956,482)
     
Dividend to member unit holder of Myeloma Health LLC  --   (240,000)
     
Net loss attributable to stockholders of Signal Genetics, Inc.  $ (5,631,931)  $ (2,196,482)
     
Basic and diluted net loss per share:    
Net loss attributable to stockholders of Signal Genetics, Inc.  $ (1.78)  $ (0.85)
     
Weighted average shares outstanding - basic and diluted  3,162,639  2,587,475

INVESTOR CONTACT: The Ruth Group David Burke Tel: 646-536-7009

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Telit Cinterion Tests Its Defense Connectivity Pitch

Updated Category News Views 107

Defense connectivity is a messy business, and Telit Cinterion is leaning straight into the mess at NATO Edge 2026 in Izmir, Turkey. From November 17 through 19, the company is using Booth L86 to show how several wireless links can live inside one mission-focused setup. That may sound like standard trade-show wallpaper, but the underlying problem is very real: military and...

Continue Reading
Hyster-Yale's $125 Million Convertible Debt Shuffle

Updated Category News Views 86

Forklifts do not make headlines often, but debt terms sure can. Hyster-Yale has proposed a $125 million private offering of convertible senior notes due November 15, 2031, with buyers able to take another $18.75 million if the initial purchasers exercise their option. For NYSE:HY holders, this is not a victory lap or a distress flare by itself. It is a refinancing...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 45

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 121

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Sysco's Northern California Labor Deal Gets Bigger

Updated Category News Views 20

One hundred forty-four drivers may not rattle a giant food distributor by themselves, but labor agreements have a habit of growing legs. Sysco's Northern California and Nevada regional contract has added members from Teamsters Locals 386 and 431, bringing its coverage above 1,100 workers. For investors watching Sysco, this is less about one afternoon's headline and more...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 164

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 112

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 38

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 112

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 95

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading

Top 5 Most Recently Viewed Articles

Shell PLC's Strategic Share Repurchase Program Explained

Updated Category News Views 198

Understanding Shell PLC's Share Repurchase Strategy Shell plc has recently made headlines with its ongoing share buyback program. On a notable date, the company announced a significant purchase of its own shares intended for cancellation. This action is a part of its broader strategy to enhance shareholder value and optimize its capital structure. Details of the Share...

Continue Reading
Teck Resources Faces Maintenance Challenges at Chile Operations

Updated Category News Views 255

Maintenance Updates from Teck Resources Limited Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) has recently reported important updates regarding maintenance challenges at its operations in Chile. A mechanical issue has emerged at the Carmen de Andacollo (CdA) site, necessitating a temporary shutdown of the SAG mill. According to the latest information,...

Continue Reading
Neinor Homes Achieves FY24 Targets and New Shareholder Returns

Updated Category News Views 151

Neinor Homes Achieves Fiscal Targets for 2024 In a recent update, Neinor Homes reports successful fulfillment of its Adjusted Net Income target of €65 million for fiscal year 2024. The company, known for its prominence in residential property development, is now poised for continued growth. With the expected announcement of its fiscal results set for the latter part of...

Continue Reading
STG Logistics Staff Earn Supply Chain Accolades

Updated Category News Views 41

There's a fresh breeze running through the corridors of STG Logistics. Why? Because two of their own have snagged some serious recognition with the 2026 Women in Supply Chain Awards. This isn't just another blip on the corporate radar—it's a salute to the powerhouse of leadership and innovation nestled within the company's ranks. Geoff Anderman, the CEO himself, was...

Continue Reading
WISeKey International Holding Ltd Unveils AGM Agenda for Stakeholders

Updated Category News Views 284

WISeKey International Holding Ltd Unveils AGM Agenda for Stakeholders WISeKey International Holding Ltd, recognized for its significant contributions in the fields of cybersecurity and IoT, has announced the essential items for consideration by its shareholders at the upcoming Annual General Meeting (AGM). This important gathering, set to foster engagement between...

Continue Reading